Literature DB >> 21371197

Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A.

M V Ragni1, C G Moore.   

Abstract

Atherosclerotic heart disease (ASHD) is a common cause of morbidity and mortality in Western society. Few studies have determined prevalence and predictors of ASHD in haemophilia (HA), a population whose survival is improving with safer blood products and effective treatments for AIDS and hepatitis C. The purpose of this study was to determine prevalence and factors associated with ASHD in haemophilia A patients in Pennsylvania. The prevalence of ASHD (myocardial infarction, angina and coronary disease), cardiac catheterization, coronary angiography, co-morbidities and in-hospital mortality were assessed on statewide ASHD discharge data, 2001-2006, from the Pennsylvania Health Care Cost Containment Council (PHC4). The prevalence of haemophilia ASHD admissions fluctuated between 6.5% and 10.5% for 2001-2006, P = 0.62. Compared with HA without ASHD, HA with ASHD were older and more likely to be hypertensive, hyperlipidemic and diabetic, all P < 0.0001, with greater severity of illness, P = 0.013. In contrast, HA and non-HA with ASHD had similar rates of hypertension, diabetes and ICD-9 specified ischaemic heart disease, including acute myocardial infarction (MI), P = 0.39, old MI, P = 0.47 and angina, P = 0.63. Rates of catheterization and angiography, P = 0.06 and P = 0.07, were marginally lower, but primary circulatory system admitting diagnoses, P = 0.29, were similar between HA and non-HA ASHD groups, as was length of stay, P = 0.14, severity of illness, P = 0.64, and in-hospital deaths, P = 0.75. Haemophilia patients with ASHD have similar cardiovascular risk factors, admitting diagnoses, severity of illness and in-hospital mortality as the general population. These findings suggest that cardiovascular prevention measures should be promoted in haemophilia.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21371197      PMCID: PMC3134626          DOI: 10.1111/j.1365-2516.2011.02501.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  20 in total

1.  Coronary atherosclerosis and cardiovascular mortality in hemophilia.

Authors:  C J Foley; L Nichols; K Jeong; C G Moore; M V Ragni
Journal:  J Thromb Haemost       Date:  2009-10-26       Impact factor: 5.824

2.  Mortality and causes of death in Dutch haemophiliacs, 1973-86.

Authors:  F R Rosendaal; I Varekamp; C Smit; A H Bröcker-Vriends; H van Dijck; J P Vandenbroucke; J Hermans; T P Suurmeijer; E Briët
Journal:  Br J Haematol       Date:  1989-01       Impact factor: 6.998

3.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.

Authors:  Jordi Rello; Daniel A Ollendorf; Gerry Oster; Montserrat Vera-Llonch; Lisa Bellm; Rebecca Redman; Marin H Kollef
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

4.  Epidemiology of haemophilia in Greece: an overview.

Authors:  E Koumbarelis; F R Rosendaal; A Gialeraki; A Karafoulidou; W M Noteboom; C Loizou; C Panayotopoulou; C Markakis; T Mandalaki
Journal:  Thromb Haemost       Date:  1994-12       Impact factor: 5.249

5.  Prevalence and risk factors for heart disease among males with hemophilia.

Authors:  Roshni Kulkarni; J Michael Soucie; Bruce L Evatt
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

6.  Haemophilia protects against ischaemic heart disease: a study of risk factors.

Authors:  F R Rosendaal; E Briët; J Stibbe; G van Herpen; J A Leuven; A Hofman; J P Vandenbroucke
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

7.  Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators.

Authors:  J M Soucie; R Nuss; B Evatt; A Abdelhak; L Cowan; H Hill; M Kolakoski; N Wilber
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

8.  Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.

Authors:  M V Ragni; S H Belle; R A Jaffe; S L Duerstein; D C Bass; C W McMillan; E W Lovrien; L M Aledort; C T Kisker; S P Stabler
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

9.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

Authors:  T Koster; A D Blann; E Briët; J P Vandenbroucke; F R Rosendaal
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

10.  Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986.

Authors:  M Triemstra; F R Rosendaal; C Smit; H M Van der Ploeg; E Briët
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391

View more
  4 in total

Review 1.  How I treat patients with inherited bleeding disorders who need anticoagulant therapy.

Authors:  Karlyn Martin; Nigel S Key
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

2.  A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Authors:  Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle
Journal:  Blood Adv       Date:  2018-06-12

Review 3.  Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B.

Authors:  Victor A Ferraris; Leonard I Boral; Alice J Cohen; Susan S Smyth; Gilbert C White
Journal:  Cardiol Rev       Date:  2015 Mar-Apr       Impact factor: 2.644

Review 4.  Comorbidities of cardiovascular disease and cancer in hemophilia patients.

Authors:  Jiaan-Der Wang
Journal:  Thromb J       Date:  2016-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.